ホームページ MAPK -Stem Cells & Wnt KLF

KLF

亜型選択性的な製品

KLF製品

  • All (3)
  • KLF阻害剤 (2)
  • KLF活性剤(1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S8196 ML264 ML264 (CID-51003603), a selectively inhibitor of kruppel-like factor 5 (KLF5),potently Inhibits Growth of Colorectal Cancer.
Genome Instability & Disease , 2023, 4:21–37
Ann Transl Med, 2022, 10(18):969
Antioxid Redox Signal, 2021, 10.1089/ars.2020.8200
S8900 SR18662 SR18662 is an optimized compund based on ML264 that inhibits Krüppel-like factor 5 (KLF5) with IC50 of 4.4 nM. SR18662 reduces the viability of multiple colorectal cancer cell lines. SR18662 induces apoptosis.
J Exp Clin Cancer Res, 2023, 42(1):25
S6963 APTO-253

APTO-253 (LOR-253, LT-253) inhibits c-Myc expression and selectively induces CDKN1A (p21), promotes G0-G1 cell-cycle arrest, and triggers apoptosis in acute myeloid leukemia (AML) cells. APTO-253 is also an inducer of KLF4 (Krüppel-like factor 4).
Cell Commun Signal, 2023, 21(1):94
S8196 ML264 ML264 (CID-51003603), a selectively inhibitor of kruppel-like factor 5 (KLF5),potently Inhibits Growth of Colorectal Cancer.
Genome Instability & Disease , 2023, 4:21–37
Ann Transl Med, 2022, 10(18):969
Antioxid Redox Signal, 2021, 10.1089/ars.2020.8200
S8900 SR18662 SR18662 is an optimized compund based on ML264 that inhibits Krüppel-like factor 5 (KLF5) with IC50 of 4.4 nM. SR18662 reduces the viability of multiple colorectal cancer cell lines. SR18662 induces apoptosis.
J Exp Clin Cancer Res, 2023, 42(1):25
S6963 APTO-253

APTO-253 (LOR-253, LT-253) inhibits c-Myc expression and selectively induces CDKN1A (p21), promotes G0-G1 cell-cycle arrest, and triggers apoptosis in acute myeloid leukemia (AML) cells. APTO-253 is also an inducer of KLF4 (Krüppel-like factor 4).
Cell Commun Signal, 2023, 21(1):94

KLF阻害剤の選択性比較

Tags: KLF inhibitor|KLF agonist|KLF activator|KLF inducer|KLF antagonist|KLF signaling pathway|KLF assay kit